Diagnostic Workup, Biopsy, Imaging, and Pathology Basics
Key Takeaways
- Cancer diagnosis usually requires tissue or cytology confirmation, with imaging and laboratory tests used to define extent, complications, and treatment readiness.
- Biopsy planning must consider safest access, adequate tissue for pathology and biomarkers, bleeding risk, anticoagulants, infection risk, and patient education.
- Pathology reports may include histology, grade, margins, lymphovascular invasion, receptor status, molecular markers, and adequacy of specimen.
- Imaging modalities answer different questions; the nurse coordinates preparation, contrast safety screening, symptom monitoring, and result follow-up.
- Escalation is required for post-biopsy bleeding, pneumothorax symptoms, infection, neurologic compromise, airway symptoms, or rapidly worsening clinical status.
Diagnostic Workup, Biopsy, Imaging, and Pathology Basics
Diagnostic Thinking in Oncology Nursing
The diagnostic workup answers several linked questions: Is cancer present? What type is it? Where did it start? How far has it spread? What biomarkers guide treatment? Is the patient safe for planned procedures or therapy? OCN-level nursing practice focuses on assessment, education, coordination, specimen awareness, and complication recognition. Nurses should not tell a patient they have cancer before provider disclosure, but they can explain planned tests and help reduce delays.
Tissue Diagnosis and Biopsy
Most cancers require tissue or cytology confirmation. Biopsy types include fine needle aspiration, core needle biopsy, excisional biopsy, incisional biopsy, punch biopsy, endoscopic biopsy, bone marrow biopsy, image-guided biopsy, surgical biopsy, and liquid biopsy adjuncts. The best approach depends on suspected cancer type, lesion location, need for architecture, tissue required for biomarker testing, patient stability, bleeding risk, and procedural risk.
Nursing preparation includes confirming allergies, anticoagulant and antiplatelet use, bleeding history, pregnancy status when relevant, renal function for contrast, infection symptoms, sedation plan, transportation needs, and baseline pain or neurologic status. Patient teaching should cover procedure purpose, positioning, expected sensations, post-procedure restrictions, when results may return, and urgent symptoms to report.
Post-biopsy complications vary by site. Lung biopsy can cause pneumothorax or hemoptysis. Liver biopsy can cause bleeding or referred shoulder pain. Bone marrow biopsy can cause localized pain or bleeding. Lumbar puncture can cause headache or neurologic symptoms. Lymph node or breast biopsy can cause hematoma or infection. The nurse escalates shortness of breath, chest pain, expanding swelling, uncontrolled bleeding, fever, severe pain, syncope, new weakness, or mental status change.
Imaging Basics
| Modality | Common oncology use | Nursing considerations |
|---|---|---|
| CT | Anatomy, staging, response, complications | Contrast allergy, renal function, hydration, metformin policy per site |
| MRI | Brain, spine, pelvis, liver, soft tissue detail | Implant screening, claustrophobia, gadolinium considerations |
| PET/CT | Metabolic activity, staging, recurrence assessment | Glucose control, fasting instructions, inflammatory false positives |
| Ultrasound | Liver, pelvis, thyroid, breast, fluid guidance | Procedure preparation, biopsy guidance, ascites evaluation |
| Modality | Common oncology use | Nursing considerations |
|---|---|---|
| Bone scan | Osteoblastic bone activity | Hydration, delayed imaging, arthritis or fracture false positives |
| Mammography | Breast screening and diagnosis | Prior images, compression education, follow-up coordination |
Pathology Report Literacy
Pathology may include specimen site, histologic type, tumor size, grade, margin status, lymphovascular invasion, perineural invasion, lymph node involvement, receptor status, immunohistochemistry, molecular findings, and adequacy. A breast cancer report may include invasive ductal carcinoma, grade, ER/PR/HER2, Ki-67, margins, and nodes. A colorectal report may include adenocarcinoma, depth of invasion, nodes, margins, lymphovascular invasion, mismatch repair status, and tumor deposits.
Histology identifies the tissue pattern, such as adenocarcinoma, squamous cell carcinoma, small cell carcinoma, melanoma, sarcoma, lymphoma, leukemia, glioma, or germ cell tumor. Cytology evaluates cells, not full tissue architecture, and may be sufficient in some settings but limited in others. Nurses should know when additional tissue may be requested for biomarkers and help coordinate outside slides or blocks.
Laboratory and Diagnostic Measures
Common diagnostic adjuncts include CBC, CMP, liver tests, renal function, coagulation tests, tumor markers, urinalysis, infection testing, endocrine labs, and disease-specific tests. Tumor markers such as PSA, CA-125, CEA, AFP, beta-hCG, CA 19-9, and thyroglobulin can support diagnosis or monitoring in selected cancers, but they are not universal screening tools and may be nonspecific. Nurses should teach patients that marker trends must be interpreted by the oncology team in context.
Coordination and Escalation
Diagnostic workups can be stressful and fragmented. Nurses reduce harm by tracking pending pathology, confirming imaging appointments, ensuring contrast instructions are understood, coordinating biopsy tissue needs, obtaining outside records, and identifying barriers. Escalation is urgent for airway compromise, spinal cord compression symptoms, superior vena cava syndrome signs, symptomatic brain lesions, sepsis, uncontrolled bleeding, or unstable laboratory findings.
A patient develops sudden shortness of breath and pleuritic chest pain after a CT-guided lung biopsy. What should the nurse suspect and do first?
Which pathology element is most directly related to whether tumor extends to the edge of a resected specimen?
Which teaching point about PET/CT is most accurate?